120 related articles for article (PubMed ID: 36630388)
1. Expression of Concern: A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
PLOS ONE Editors
PLoS One; 2023; 18(1):e0279805. PubMed ID: 36630388
[No Abstract] [Full Text] [Related]
2. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
[TBL] [Abstract][Full Text] [Related]
3. Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma.
Koike C; Okudela K; Matsumura M; Mitsui H; Suzuki T; Arai H; Kataoka T; Ishikawa Y; Umeda S; Tateishi Y; Ohashi K
Histol Histopathol; 2021 Mar; 36(3):305-315. PubMed ID: 33368138
[TBL] [Abstract][Full Text] [Related]
4. Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
Matsumura M; Okudela K; Nakashima Y; Mitsui H; Denda-Nagai K; Suzuki T; Arai H; Umeda S; Tateishi Y; Koike C; Kataoka T; Irimura T; Ohashi K
PLoS One; 2019; 14(4):e0215237. PubMed ID: 30973916
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
6. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
7. Stromal micropapillary pattern and CD44s expression predict worse outcome in lung adenocarcinomas with micropapillary pattern.
Fu Y; Zha J; Wu Q; Tang Y; Wang W; Zhou Q; Jiang L
Pathol Res Pract; 2023 Aug; 248():154595. PubMed ID: 37343380
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
Rekhtman N; Ang DC; Riely GJ; Ladanyi M; Moreira AL
Mod Pathol; 2013 Oct; 26(10):1307-19. PubMed ID: 23619604
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas.
Cai YR; Dong YJ; Wu HB; Liu ZC; Zhou LJ; Su D; Chen XJ; Zhang L; Zhao YL
Sci Rep; 2016 Apr; 6():23755. PubMed ID: 27046167
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.
Chantranuwat C; Sriuranpong V; Huapai N; Chalermchai T; Leungtaweeboon K; Voravud N; Mutirangura A
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S322-9. PubMed ID: 16623049
[TBL] [Abstract][Full Text] [Related]
13. Stromal micropapillary predominant lung adenocarcinoma: A rare histological phenotype with poor prognosis.
Hayakawa T; Tajima S; Tsukui M; Takanashi Y; Neyatani H; Funai K
Respirol Case Rep; 2016 Nov; 4(6):e00203. PubMed ID: 28031838
[TBL] [Abstract][Full Text] [Related]
14. EGFR, KRAS, and BRAF mutational profiles of female patients with micropapillary predominant invasive lung adenocarcinoma.
Demirağ F; Yılmaz A; Yılmaz Demirci N; Yılmaz Ü; Erdoğan Y
Turk J Med Sci; 2017 Nov; 47(5):1354-1361. PubMed ID: 29151304
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression.
Cai Y; Wu H; Shi X; Dong Y; Chang X; Zhang L; Zhou L; Su D; Yang M
BMC Cancer; 2020 Feb; 20(1):148. PubMed ID: 32093629
[TBL] [Abstract][Full Text] [Related]
16. Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.
Bjaanaes MM; Halvorsen AR; Solberg S; Jørgensen L; Dragani TA; Galvan A; Colombo F; Anderlini M; Pastorino U; Kure E; Børresen-Dale AL; Brustugun OT; Helland A
Int J Cancer; 2014 Oct; 135(8):1812-21. PubMed ID: 24599520
[TBL] [Abstract][Full Text] [Related]
17. Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction.
Yeh YC; Wu YC; Chen CY; Wang LS; Hsu WH; Chou TY
J Clin Pathol; 2012 Oct; 65(10):910-8. PubMed ID: 22813729
[TBL] [Abstract][Full Text] [Related]
18. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
[TBL] [Abstract][Full Text] [Related]
20. Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates.
Kamata T; Yoshida A; Shiraishi K; Furuta K; Kosuge T; Watanabe S; Asamura H; Tsuta K
Histopathology; 2016 Feb; 68(3):356-66. PubMed ID: 26109197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
